Cargando…

Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1‐Cre and LSL‐Kras(G12D)) mice

Alcohol is a risk factor for pancreatic cancer. However, the molecular mechanism by which chronic alcohol consumption influences pancreatic cancer development is not well understood. We have recently demonstrated that chronic ethanol exposure of pancreatic normal ductal epithelial cells (HPNE) induc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Wei, Ma, Yiming, Roy, Sanjit K., Srivastava, Rashmi, Shankar, Sharmila, Srivastava, Rakesh K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743655/ https://www.ncbi.nlm.nih.gov/pubmed/34859959 http://dx.doi.org/10.1111/jcmm.17092

Ejemplares similares

Development of thymic tumor in [LSL:Kras(G12D); Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis
por: Liot, Sophie, et al.
Publicado: (2021)

Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered Kras(G12D);Pdx1-Cre mouse (KC) model
por: Rachagani, Satyanarayana, et al.
Publicado: (2015)

Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras(G12D/+);Tp53(R172H/+) (KPC) mice, a genetically engineered model of pancreatic cancer
por: Vilimas, Tomas, et al.
Publicado: (2018)

LSL-Kras(G12D); LSL-Trp53(R172H/+); Ink4(flox/+); Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer
por: Ma, Lixiang, et al.
Publicado: (2017)

HMGA1 expression levels are elevated in pancreatic intraepithelial neoplasia cells in the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer
por: Veite-Schmahl, Michelle J, et al.
Publicado: (2017)

Chronic ethanol exposure of human pancreatic normal ductal epithelial cells induces cancer stem cell phenotype through SATB2
por: Yu, Wei, et al.
Publicado: (2018)

NMR-based metabolic profiling of urine, serum, fecal, and pancreatic tissue samples from the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer
por: Schmahl, Michelle J., et al.
Publicado: (2018)

The Mouse Model of Pancreatic Cancer Atlas (MMPCA) for classification of pancreatic cancer lesions: A large histological investigation of the Ptf1a(Cre/+);LSL-Kras(G12D/+) transgenic mouse model of pancreatic cancer
por: Veite-Schmahl, Michelle J., et al.
Publicado: (2017)

The Rho/MRTF pathway inhibitor CCG-222740 reduces stellate cell activation and modulates immune cell populations in Kras(G12D); Pdx1-Cre (KC) mice
por: Leal, Ana S., et al.
Publicado: (2019)

PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance
por: Roy, Nilotpal, et al.
Publicado: (2016)

Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
por: Roy, Sanjit K, et al.
Publicado: (2010)

Riluzole regulates pancreatic cancer cell metabolism by suppressing the Wnt-β-catenin pathway
por: Roy, Sanjit K., et al.
Publicado: (2022)

Resveratrol Inhibits Growth of Orthotopic Pancreatic Tumors through Activation of FOXO Transcription Factors
por: Roy, Sanjit K., et al.
Publicado: (2011)

Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker
por: Yu, Wei, et al.
Publicado: (2016)

α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice
por: Verma, Raj Kumar, et al.
Publicado: (2016)

PDX1, a key factor in pancreatic embryogenesis, can exhibit antimetastatic activity in pancreatic ductal adenocarcinoma
por: Kondratyeva, Liya G, et al.
Publicado: (2019)

Embelin Suppresses Growth of Human Pancreatic Cancer Xenografts, and Pancreatic Cancer Cells Isolated from Kras(G12D) Mice by Inhibiting Akt and Sonic Hedgehog Pathways
por: Huang, Minzhao, et al.
Publicado: (2014)

KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
por: Yu, Shuang-Ni, et al.
Publicado: (2016)

Inhibition of pancreatic cancer stem cell characteristics by α‐Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog
por: Ma, Yiming, et al.
Publicado: (2019)

Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
por: Liu, Yu-Huei, et al.
Publicado: (2022)

KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
por: Zhang, Zining, et al.
Publicado: (2023)

Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2023)

Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and Kras(G12D) Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition
por: Shankar, Sharmila, et al.
Publicado: (2011)

Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
por: Nalls, Dara, et al.
Publicado: (2011)

KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
por: Gurreri, Enrico, et al.
Publicado: (2023)

Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer
por: Singh, Kanchan, et al.
Publicado: (2020)

Correction to: Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer
por: Singh, Kanchan, et al.
Publicado: (2021)

Diabetes Caused by Elastase-Cre-Mediated Pdx1 Inactivation in Mice
por: Kodama, Sota, et al.
Publicado: (2016)

Notch1 Is Not Required for Acinar-to-Ductal Metaplasia in a Model of Kras-Induced Pancreatic Ductal Adenocarcinoma
por: Avila, Jacqueline L., et al.
Publicado: (2012)

E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
por: Sommariva, Michele, et al.
Publicado: (2020)

The Pancreatic and Duodenal Homeobox Protein PDX-1 Regulates the Ductal Specific Keratin 19 through the Degradation of MEIS1 and DNA Binding
por: von Burstin, Johannes, et al.
Publicado: (2010)

Pancreatic Ductal Organoids React Kras Dependent to the Removal of Tumor Suppressive Roadblocks
por: Perkhofer, Lukas, et al.
Publicado: (2019)

KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities
por: Luchini, Claudio, et al.
Publicado: (2020)

Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma
por: Ashok Kumar, Prashanth, et al.
Publicado: (2023)

Impact of KRAS Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma
por: Yousef, Abdelrahman, et al.
Publicado: (2023)

S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
por: Srivastava, K., et al.
Publicado: (2023)

The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives
por: Quoc Lam, Bao, et al.
Publicado: (2020)

Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms
por: Singh, Brahma N., et al.
Publicado: (2011)

Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma
por: Wang, Wulin, et al.
Publicado: (2020)

An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bfd55f6f5f8ignu20m8rfkkgp5